These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10912127)

  • 1. [Antibiotic therapy. Strong bacteriocidal effect prevents development of resistant pathogens].
    MMW Fortschr Med; 1999 Oct; 141(43):55. PubMed ID: 10912127
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility to selected antibiotics of Streptococcus pneumoniae and Streptococcus pyogenes strains isolated from patients with respiratory tract infections.
    Mazur E; Ligieza J; Niedźwiadek J; Polak G; Kozioł-Montewka M; Hencner Z
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():407-10. PubMed ID: 11205800
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistant microorganisms in head and neck infections.
    Mazzulli T
    J Otolaryngol; 2005 Jun; 34 Suppl 1():S2-6. PubMed ID: 16089233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide resistance in Streptococci and Haemophilus influenzae.
    Bozdogan B; Appelbaum PC
    Clin Lab Med; 2004 Jun; 24(2):455-75. PubMed ID: 15177849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
    Brown SD; Rybak MJ
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic resistance in respiratory tract infections: what can we do?].
    Flückiger U
    Praxis (Bern 1994); 2001 May; 90(21):931-4. PubMed ID: 11441707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan.
    Hsueh PR; Shyr JM; Wu JJ
    Clin Microbiol Infect; 2006 Mar; 12(3):296-8. PubMed ID: 16451421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crisis of resistant pathogens in respiratory tract infections--use of pharmacodynamic principles.
    Palavecino EL
    Am J Manag Care; 2001 Jun; 7(6 Suppl):S170-7. PubMed ID: 11424585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance patterns of selected respiratory tract pathogens in Poland.
    Skoczyńska A; Kadłubowski M; Waśko I; Fiett J; Hryniewicz W
    Clin Microbiol Infect; 2007 Apr; 13(4):377-83. PubMed ID: 17359321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of oral antibiotics against respiratory tract pathogens in Spain.
    Calvo A; Amores R; Valero E; Fuentes F; Gómez-Lus ML; Prieto J;
    Rev Esp Quimioter; 2003 Dec; 16(4):436-43. PubMed ID: 14961138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of bacterial resistance to macrolides.
    Halpern MT; Schmier JK; Snyder LM; Asche C; Sarocco PW; Lavin B; Nieman R; Mandell LA
    J Antimicrob Chemother; 2005 May; 55(5):748-57. PubMed ID: 15772147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate antibiotic use in treating respiratory tract infections.
    Poole MD
    Am J Manag Care; 2001 Jun; 7(6 Suppl):S178-82. PubMed ID: 11424586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries.
    Song JH; Ko KS; Lee MY; Park S; Baek JY; Lee JY; Heo ST; Kwon KT; Ryu SY; Oh WS; Peck KR; Lee NY
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):445-50. PubMed ID: 16949783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan.
    Inoue M; Kohno S; Kaku M; Yamaguchi K; Igari J; Yamanaka K
    Int J Infect Dis; 2005 Jan; 9(1):27-36. PubMed ID: 15603993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens.
    Gómez-Lus R; Granizo JJ; Aguilar L; Bouza E; Gutierrez A; García-de-Lomas J
    J Clin Microbiol; 1999 Oct; 37(10):3384-6. PubMed ID: 10488213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic susceptibility of pathogens isolated from patients with community-acquired respiratory tract infections in Pakistan--the active study.
    Zafar A; Hussain Z; Lomama E; Sibille S; Irfan S; Khan E
    J Ayub Med Coll Abbottabad; 2008; 20(1):7-9. PubMed ID: 19024175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing antibiotic resistance of streptococcus species in New York City.
    Lin K; Tierno PM; Komisar A
    Laryngoscope; 2004 Jul; 114(7):1147-50. PubMed ID: 15235338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational use of antibiotics to treat respiratory tract infections.
    File TM; Hadley JA
    Am J Manag Care; 2002 Aug; 8(8):713-27. PubMed ID: 12212759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.